ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during October 16-17, 2017 at Osaka, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Engineering and Biomedical Engineering.
Pharma Engineering 2017 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical and Biomedical Engineering. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Technology, Medical Devices & Imaging, Cell & Tissue Engineering, Bioinstrumentation & Bio imaging and Pharmaceutical Sciences.
ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
2017 Highlights:
300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
20+ Exhibitors
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings
Summary:
Pharma Engineering 2017 welcomes attendees, presenters, and exhibitors from all over the world to Osaka, Japan. We are delighted to invite you all to attend and register for the “International Conference on Pharmaceutical and Biomedical Engineering (Pharma Engineering 2017) which is going to be held during October 16-17, 2017 at Osaka, Japan. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Pharma Engineering 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Pharma Engineering 2017 organizing committee look forward to meet you at Osaka, Japan.
Importance and Scope:
Pharma Engineering 2017 addresses current & future trends at the interface of pharmaceutical and biochemical engineering, pharmaceutical manufacturing technology, micro and process technology. It emphasizes on the use of drugs, analysis of drugs, related materials and endogenous compounds and their processing. It intends to provide a platform for enthusiastic dialogs and trade between these controls. Biomedical Engineering deals with the treatment for various diseases and therapy; manufacture and development various medical devices, prostheses and bio instruments used for diagnosis.
Why Osaka, Japan?
Japan is the second-largest individual pharmaceutical market in the world. It accounts for less than 10% of the total global pharmaceutical market. The country’s pharma market is expected to grow annually by ~2.2%. Shionogi & Co's new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan. Osaka is a large port city and commercial centre on the Japanese island of Honshu. Osaka is famous for modern architecture, nightlife and hearty street food. The 16th-century shogunate Osaka Castle, which has undergone several restorations, is its main historical landmark. It's surrounded by a moat and park with plum, peach and cherry-blossom trees. Sumiyoshi-taisha is among Japan’s oldest Shinto shrines.
Track 1:Pharmaceutical Engineering
Track 1-1Rational drug design
Track 1-2Novel drug delivery
Track 1-3Targeted drug delivery
Track 1-4Processing of liquid and dispersed phase systems
Track 1-5Pharmaceutical packaging technology
Track 2:Drug Engineering
Track 2-1Biopharmaceuticals
Track 2-2Biologic drugs
Track 2-3Drug manufacture
Track 2-4Chemical synthesis
Track 3:Pharmaceutical Technology
Track 3-1Bioprocessing
Track 3-2Supply chain safety
Track 3-3Molecular isotopic engineering
Track 3-4Medication management
Track 4:Pharmaceutical Analysis
Track 4-1Chemical analysis
Track 4-2Traditional chinese medicine
Track 4-3Medicinal materials
Track 4-4Biotech drug
Track 4-5Clinical laboratory and Bio analysis
Track 4-6Analysis of crude drugs
Track 5:Process Engineering
Track 5-1Supporting tools
Track 5-2Quality assurance
Track 5-3Quality control
Track 5-4Good manufacturing process
Track 5-5Process control
Track 5-6Process design
Track 6:Medical Devices and Imaging
Track 6-1Radiography and echocardiography
Track 6-2Magnetic resonance imaging (MRI)
Track 6-3Elastography and Ultrasonography
Track 6-4Thermography and Tomography
Track 6-5Biomedical Instrumentation measurements
Track 6-6Instrumentation for psychophysiological measurements
Track 6-7Pacemakers and Defibrillators
Track 6-8Ophthalmic and ENT instruments
Track 6-9CT and PET scanners
Track 7:Biomedical Engineering
Track 7-1Self-Designed biomedical engineering
Track 7-2Pattern recognition,Clustering and Classification
Track 7-3Systems biology
Track 7-4Structure Prediction and Variations
Track 7-5Sequence and image analysis
Track 7-6Genomics, Proteomics and Transcriptomics
Track 7-7Simulation and Modelling
Track 7-8Clinical engineering
Track 7-9Biomedical optics
Track 7-10Biomedical computing and analysis
Track 7-11Model Design and Evaluation
Track 8:Biomechanics
Track 8-1Continuum biomechanics
Track 8-2Ergonomy
Track 8-3Musculoskeletal and Orthopaedic Biomechanics
Track 8-4Animal locomotion and gait analysis
Track 8-5Injury Biomechanics
Track 8-6Cellular biomechanics
Track 8-7Plant biomechanics
Track 8-8Comparative biomechanics
Track 8-9Bio tribology
Track 8-10Bio fluid mechanics
Track 8-11Allometry
Track 9:Cell & Tissue Engineering
Track 9-1Bone bioengineering
Track 9-2Organ preservation
Track 9-3Cartilage biology
Track 9-4Nerve regeneration
Track 9-5Nanomedicine
Track 9-6Quantitative aspects
Track 9-7Microscale biocomplexity
Track 9-8Stem cells and Functional tissue
Track 9-9Next generation sequencing
Track 9-10Cellular and Tissue Engineering
Track 9-11Cell fate mechanisms
Track 10:Bioinstrumentation and Bio imaging
Track 10-1Recent advances in patient treatment and care
Track 10-2Recent Advances in spectroscopy
Track 10-3Pharmaceutical research and early development informatics enabling technologies
Track 10-4Green techniques for medicinal chemistry
Track 10-5High-throughput screening and Laboratory automation
Track 10-6Computational molecular systems
Track 11:Biomaterials
Track 11-1Vascular grafts
Track 11-2Bionics
Track 11-3Implant (medicine), Orthotics & Prosthesis
Track 11-4Biopolymers
Track 11-5Heart valves
Track 11-6Sustainable materials
Track 12:Genetic Engineering
Track 12-1Transformation
Track 12-2Genome editing
Track 12-3Genetically modified organisms
Track 12-4Gene knockout
Track 12-5Traditional breeding
Track 12-6Genetically engineered plants
Track 12-7Transgenic animals
Track 12-8Polymerase chain reaction
Track 12-9Electroporation
Track 13:Regulatory Compliance
Track 13-1Quality by Design (QbD)
Track 13-2Regulatory issues in the pharmaceutical industry
Track 13-3Scope of regulatory affairs
Track 13-4Importance of regulatory affairs
Track 13-5Current status of drug safety and pharmacovigilance
06月12日
2017
06月13日
2017
初稿截稿日期
注册截止日期
留言